指南与共识母胎医学

意大利2023年孕期巨细胞病毒筛查建议解读

Screening of Cytomegalovirus Infection in Pregnant Women. Recommendation by the Italian National Institute of Health and Ministry of Health, December 2023
RSS 订阅 · Prenatal Diagnosis · 2026-02-10

该建议基于系统综述、随机对照试验和观察性研究,支持在孕期开展普遍性CMV血清学筛查。核心依据为伐昔洛韦可降低原发感染孕妇的垂直传播,且在中高血清流行率人群中普遍筛查具有成本效益。

要点

  • 意大利新建议支持孕早期首次产检即行CMV血清学筛查。
  • 血清阴性孕妇应每月复查至24周,并接受预防信息指导。
  • 伐昔洛韦用于早期原发感染可显著降低母婴垂直传播。

核心结论

  • 新建议取代既往因缺乏有效阻断措施而不推荐常规筛查的立场。

研究设计与样本

  • 本文总结意大利国家卫生研究院代表卫生部发布的国家建议及其证据与决策过程。
  • 建议基于系统综述,纳入随机对照试验、观察性研究和系统综述。

主要发现

  • 近期高质量证据显示,母体原发感染早期使用伐昔洛韦可显著降低垂直传播。
  • 成本效益分析支持在育龄女性CMV血清流行率为中高水平的地区开展普遍筛查。

关键数值与推荐

  • 建议首次产检在孕早期进行CMV血清学筛查。
  • 血清阴性孕妇每月检测一次直至孕24周。
  • 所有孕妇均应接受以CMV预防为重点的信息指导。

临床怎么用

  • 临床可在孕早期首诊时纳入CMV血清学筛查,并对阴性者按月复测至24周。
  • 对母体原发感染早期可考虑采用伐昔洛韦干预以降低垂直传播。

局限性

  • 本文未提供信度区间、P值、样本量或具体剂量等量化数据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

ABSTRACT Congenital cytomegalovirus (cCMV) is the most common congenital infection and a leading cause of non-genetic sensorineural hearing loss and neurodevelopmental disability in newborns. Despite its clinical burden, routine CMV screening in pregnancy has not been recommended so far due to the lack of effective treatment to prevent transplacental transmission. In December 2023, the Italian National Institute of Health, on behalf of the Ministry of Health, has issued a new recommendation supporting universal CMV serological screening during pregnancy. This recommendation is based on the results of a systematic review of the literature, including randomized controlled trials, observational studies, and systematic reviews. Recent high-quality evidence demonstrates that valacyclovir significantly reduces vertical transmission when administered during early primary maternal infection. In addition, cost-effectiveness analyses support universal screening in settings with moderate-to-high CMV seroprevalence among childbearing age women. Based on this evidence, the updated Italian guideline recommends CMV serological screening at the first antenatal visit within the first trimester, with monthly testing until 24 weeks in seronegative women, and targeted information on CMV prevention to all pregnant women. This article summarizes the evidence and decision-making process behind this new national recommendation and highlights its potential relevance to other countries currently considering the implementation of a similar screening policy.

来源:Prenatal Diagnosis,查看原文。版权归原作者所有。

引用

  1. Prenatal Diagnosis:Screening of Cytomegalovirus Infection in Pregnant Women. Recommendation by the Italian National Institute of Health and Ministry of Health, December 2023

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。